Table 3 |
|||||
|
Final subject disposition by group and visit |
|||||
|
Group |
|||||
|
UP446250 mgs/day |
UP446500 mgs/day |
Celecoxib 200 mgs/day |
Placebo |
||
|
|
|||||
|
Visit |
Baseline |
15 |
15 |
15 |
15 |
|
30 Days |
15 |
15 |
13 |
15 |
|
|
60 Days |
14 |
13 |
13 |
13 |
|
|
90 Days |
14 |
13 |
12 |
13 |
|
|
|
|||||
|
Sampalis and Brownell Nutrition Journal 2012 11:21 doi:10.1186/1475-2891-11-21 |
|||||
